5-(2-(4-((5-(AZIDOMETHYL)-2-BUTYL-4-CHLOROIMIDAZOL-1-YL)METHYL)PHENYL)PHENYL)-2H-TETRAZOLE
UNII 6QUU26LZ5H
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(2-(4-((5-(azidomethyl)-2-butyl-4-chloroimidazol-1-yl)methyl)phenyl)phenyl)-2h-tetrazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6QUU26LZ5H.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 727718-93-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H22ClN9 WSECDZBYSJWHFL-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(2-(4-((5-(azidomethyl)-2-butyl-4-chloroimidazol-1-yl)methyl)phenyl)phenyl)-2h-tetrazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.